{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:09:39Z","timestamp":1789474179197,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","award":["2023YG005"],"award-info":[{"award-number":["2023YG005"]}],"id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010587"],"award-info":[{"award-number":["2024A1515010587"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030076"],"award-info":[{"award-number":["82030076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41375-026-03051-9","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:07:55Z","timestamp":1784034475000},"page":"1985-1996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-3711","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8835-8370","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-7473","authenticated-orcid":false,"given":"Yonghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-2665","authenticated-orcid":false,"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"3051_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"3051_CR2","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","volume":"23","author":"LF Peterson","year":"2004","unstructured":"Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene. 2004;23:4255\u201362.","journal-title":"Oncogene"},{"key":"3051_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V86.1.1.bloodjournal8611","volume":"86","author":"G Nucifora","year":"1995","unstructured":"Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 1995;86:1\u201314.","journal-title":"Blood"},{"key":"3051_CR4","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1128\/MCB.21.19.6470-6483.2001","volume":"21","author":"JM Amann","year":"2001","unstructured":"Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol. 2001;21:6470\u201383.","journal-title":"Mol Cell Biol"},{"key":"3051_CR5","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1074\/jbc.RA119.010707","volume":"295","author":"C Guo","year":"2020","unstructured":"Guo C, Li J, Steinauer N, Wong M, Wu B, Dickson A, et al. Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML. J Biol Chem. 2020;295:4212\u201323.","journal-title":"J Biol Chem"},{"key":"3051_CR6","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.1074\/jbc.M010582200","volume":"276","author":"D Hildebrand","year":"2001","unstructured":"Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB. Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem. 2001;276:9889\u201395.","journal-title":"J Biol Chem"},{"key":"3051_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1182\/blood-2012-07-444729","volume":"121","author":"Y Li","year":"2013","unstructured":"Li Y, Gao L, Luo X, Wang L, Gao X, Wang W, et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN\/PI3K signal pathway. Blood. 2013;121:499\u2013509.","journal-title":"Blood"},{"key":"3051_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.15252\/emmm.201607180","volume":"9","author":"Y Li","year":"2017","unstructured":"Li Y, Ning Q, Shi J, Chen Y, Jiang M, Gao L, et al. A novel epigenetic AML1-ETO\/THAP10\/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis. EMBO Mol Med. 2017;9:933\u201349.","journal-title":"EMBO Mol Med"},{"key":"3051_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107691","volume":"31","author":"M Nafria","year":"2020","unstructured":"Nafria M, Keane P, Ng ES, Stanley EG, Elefanty AG, Bonifer C. Expression of RUNX1-ETO rapidly alters the chromatin landscape and growth of early human myeloid precursor cells. Cell Rep. 2020;31:107691.","journal-title":"Cell Rep"},{"key":"3051_CR10","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.05.005","volume":"19","author":"J Loke","year":"2017","unstructured":"Loke J, Assi SA, Imperato MR, Ptasinska A, Cauchy P, Grabovska Y, et al. RUNX1-ETO and RUNX1-EVI1 differentially reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML. Cell Rep. 2017;19:1654\u201368.","journal-title":"Cell Rep"},{"key":"3051_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood-2015-03-626671","volume":"127","author":"Y Li","year":"2016","unstructured":"Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, et al. Genome-wide studies identify a novel interplay between AML1 and AML1\/ETO in t(8;21) acute myeloid leukemia. Blood. 2016;127:233\u201342.","journal-title":"Blood"},{"key":"3051_CR12","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/leu.2015.56","volume":"29","author":"XN Gao","year":"2015","unstructured":"Gao XN, Yan F, Lin J, Gao L, Lu XL, Wei SC, et al. AML1\/ETO cooperates with HIF1alpha to promote leukemogenesis through DNMT3a transactivation. Leukemia. 2015;29:1730\u201340.","journal-title":"Leukemia"},{"key":"3051_CR13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm1443","volume":"12","author":"M Yan","year":"2006","unstructured":"Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med. 2006;12:945\u20139.","journal-title":"Nat Med"},{"key":"3051_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41375-019-0551-4","volume":"34","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Schwarz P, Giaimo BD, Bedzhov I, Corbacioglu A, Weber D, et al. Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML). Leukemia. 2020;34:630\u20134.","journal-title":"Leukemia"},{"key":"3051_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41375-023-02063-z","volume":"38","author":"M Yan","year":"2024","unstructured":"Yan M, Liu M, Davis AG, Stoner SA, Zhang DE. Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation. Leukemia. 2024;38:31\u201344.","journal-title":"Leukemia"},{"key":"3051_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/ng.3709","volume":"48","author":"ZJ Faber","year":"2016","unstructured":"Faber ZJ, Chen X, Gedman AL, Boggs K, Cheng J, Ma J, et al. The genomic landscape of core-binding factor acute myeloid leukemias. Nat Genet. 2016;48:1551\u20136.","journal-title":"Nat Genet"},{"key":"3051_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/leu.2009.104","volume":"23","author":"B Jiao","year":"2009","unstructured":"Jiao B, Wu CF, Liang Y, Chen HM, Xiong SM, Chen B, et al. AML1-ETO9a is correlated with C-KIT overexpression\/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2. Leukemia. 2009;23:1598\u2013604.","journal-title":"Leukemia"},{"key":"3051_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","volume":"20","author":"T Kurosaki","year":"2019","unstructured":"Kurosaki T, Popp MW, Maquat LE. Quality and quantity control of gene expression by nonsense-mediated mRNA decay. Nat Rev Mol Cell Biol. 2019;20:406\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3051_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrm4063","volume":"16","author":"S Lykke-Andersen","year":"2015","unstructured":"Lykke-Andersen S, Jensen TH. Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat Rev Mol Cell Biol. 2015;16:665\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3051_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41375-023-02098-2","volume":"38","author":"S Miliara","year":"2024","unstructured":"Miliara S, Cozzi E, Zhong X, Chan I, Ekwall K, Lehmann S, et al. The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia. Leukemia. 2024;38:663\u20136.","journal-title":"Leukemia"},{"key":"3051_CR21","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/nar\/gkw010","volume":"44","author":"N Hug","year":"2016","unstructured":"Hug N, Longman D, Caceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016;44:1483\u201395.","journal-title":"Nucleic Acids Res"},{"key":"3051_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tig.2020.08.010","volume":"37","author":"Z Yi","year":"2021","unstructured":"Yi Z, Sanjeev M, Singh G. The branched nature of the nonsense-mediated mRNA decay pathway. Trends Genet. 2021;37:143\u201359.","journal-title":"Trends Genet"},{"key":"3051_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","volume":"22","author":"K Tan","year":"2022","unstructured":"Tan K, Stupack DG, Wilkinson MF. Nonsense-mediated RNA decay: an emerging modulator of malignancy. Nat Rev Cancer. 2022;22:437\u201351.","journal-title":"Nat Rev Cancer"},{"key":"3051_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.phrs.2018.04.004","volume":"133","author":"J Maiuolo","year":"2018","unstructured":"Maiuolo J, Maretta A, Gliozzi M, Musolino V, Carresi C, Bosco F, et al. Ethanol-induced cardiomyocyte toxicity implicit autophagy and NFkB transcription factor. Pharm Res. 2018;133:141\u201350.","journal-title":"Pharm Res"},{"key":"3051_CR25","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1261\/rna.079277.122","volume":"28","author":"N Hug","year":"2022","unstructured":"Hug N, Aitken S, Longman D, Raab M, Armes H, Mann AR, et al. A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation. RNA. 2022;28:1224\u201338.","journal-title":"RNA"},{"key":"3051_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","volume":"37","author":"F Supek","year":"2021","unstructured":"Supek F, Lehner B, Lindeboom RGH. To NMD or not To NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases. Trends Genet. 2021;37:657\u201368.","journal-title":"Trends Genet"},{"key":"3051_CR27","doi-asserted-by":"publisher","first-page":"4 29 21","DOI":"10.1002\/cpmb.44","volume":"120","author":"A Mayer","year":"2017","unstructured":"Mayer A, Churchman LS. A detailed protocol for subcellular RNA sequencing (subRNA-seq). Curr Protoc Mol Biol. 2017;120:4 29 21\u201324 29 18.","journal-title":"Curr Protoc Mol Biol"},{"key":"3051_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RG Verhaak","year":"2009","unstructured":"Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94:131\u20134.","journal-title":"Haematologica"},{"key":"3051_CR29","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1182\/blood-2010-03-270991","volume":"116","author":"HJ de Jonge","year":"2010","unstructured":"de Jonge HJ, Valk PJ, Veeger NJ, ter Elst A, den Boer ML, Cloos J, et al. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood. 2010;116:1747\u201354.","journal-title":"Blood"},{"key":"3051_CR30","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/leu.2012.49","volume":"26","author":"A Ptasinska","year":"2012","unstructured":"Ptasinska A, Assi SA, Mannari D, James SR, Williamson D, Dunne J, et al. Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. 2012;26:1829\u201341.","journal-title":"Leukemia"},{"key":"3051_CR31","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1182\/blood-2002-05-1589","volume":"101","author":"O Heidenreich","year":"2003","unstructured":"Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, et al. AML1\/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood. 2003;101:3157\u201363.","journal-title":"Blood"},{"key":"3051_CR32","doi-asserted-by":"crossref","unstructured":"Kanellis DC, Espinoza JA, Zisi A, Sakkas E, Bartkova J, Katsori AM, et al. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Sci Adv. 2021;7:eabf7561.","DOI":"10.1126\/sciadv.abf7561"},{"key":"3051_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17526-5","volume":"11","author":"K Litchfield","year":"2020","unstructured":"Litchfield K, Reading JL, Lim EL, Xu H, Liu P, Al-Bakir M, et al. Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nat Commun. 2020;11:3800.","journal-title":"Nat Commun"},{"key":"3051_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04339-7","volume":"12","author":"ZH Feng","year":"2021","unstructured":"Feng ZH, Zheng L, Yao T, Tao SY, Wei XA, Zheng ZY, et al. EIF4A3-induced circular RNA PRKAR1B promotes osteosarcoma progression by miR-361-3p-mediated induction of FZD4 expression. Cell Death Dis. 2021;12:1025.","journal-title":"Cell Death Dis"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03051-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:02:02Z","timestamp":1787684522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03051-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3051"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03051-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant institutional guidelines and regulations. The study involving human samples was approved by the Ethics Committee of Shenzhen University General Hospital, Shenzhen University Medical School, China (KYLLKS-20260112A). Patient and healthy donor samples were collected under the approved protocol, and informed consent was obtained from all participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}